United Therapeutics | UTHR - Passivo Circulante





Passivo Circulante Alterar Data
Amarin USD 164.2M 15.45M 2026-06
Ardelyx USD 109.57M 20.96M 2026-03
Baxter International USD 3.59B 102M 2026-06
Bayer EUR 32.27B 1.19B 2026-06
BioCryst Pharmaceuticals USD 208.85M 13.46M 2026-06
Biogen USD 3.92B 918.2M 2026-06
BioMarin Pharmaceutical USD 1.66B 870.84M 2026-06
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Gilead Sciences USD 11.02B 1.54B 2026-06
GlaxoSmithKline GBP 21.53B 895M 2026-06
Halozyme Therapeutics USD 344.44M 18.77M 2026-06
Insmed USD 438.74M 77.74M 2026-06
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
J&J USD 54.9B 2.82B 2026-06
Lexicon Pharmaceuticals USD 9.9M 10.97M 2026-03
Moderna USD 2.53B 139M 2026-06
Omeros USD 85.5M 2.28M 2025-06
Pfizer USD 32.65B 1.7B 2026-06
PTC Therapeutics USD 771.07M 152.54M 2026-06
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
Teva Pharmaceutical Industries USD 15.65B 2.11B 2026-06
United Therapeutics USD 607.8M 8.7M 2026-06
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06